i Hepatitis C virus (HCV) interacts with cellular components and modulates their activities for its own benefit. These interactions have been postulated as a target for antiviral treatment, and some candidate molecules are currently in clinical trials. The multifunctional cellular kinase Akt/protein kinase B (PKB) must be activated to increase the efficacy of HCV entry but is rapidly inactivated as the viral replication cycle progresses. Viral components have been postulated to be responsible for Akt/PKB inactivation, but the underlying mechanism remained elusive. In this study, we show that HCV polymerase NS5B interacts with Akt/ PKB. In the presence of transiently expressed NS5B or in replicon-or virus-infected cells, NS5B changes the cellular localization of Akt/PKB from the cytoplasm to the perinuclear region. Sequestration of Akt/PKB by NS5B could explain its exclusion from its participation in early Akt/PKB inactivation. The NS5B-Akt/PKB interaction represents a new regulatory step in the HCV infection cycle, opening possibilities for new therapeutic options. As an obligate parasite, HCV usurps cellular functions and pathways to complete its replication cycle, and some of these routes are related to cell cycle control (2). The Akt/protein kinase B (PKB) family of serine/threonine protein kinases are involved in several signaling pathways that can impact the outcome of viral infections. Akt/PKB resides in the cytosol in an inactive conformation. Initial stimulation of the cell causes activation of a cell surface receptor and subsequently phosphorylation of phosphatidylinositol 3-kinase (PI3K). Activated PI3K is responsible of the formation of phosphatidylinositol(3,4,5)-trisphosphate second messenger. Akt interacts with these phosphoinositides and is recruited to the membrane, where it can be fully activated by PDK1 and other kinases. The Akt/PKB pathway is involved in processes as disparate as nutrient metabolism, regulation of protein synthesis, autophagy, and the balance of apoptosis versus cell survival and proliferation, the latter being critical for the outcome of viral infections (3-6). Akt/PKB can influence the virus-host interaction by several mechanisms. The translational repressors 4E-BPs are eukaryotic translation initiation factor 4E (eIF4E)-binding proteins that prevent cap-dependent translation of cellular mRNAs. Akt/PKB is needed for the inactivation of 4E-BPs, which occurs through a phosphorylation reaction that requires FRAP/mammalian target of rapamycin (mTOR) and results in activation of cellular translation (7). Akt/PKB is the downstream target of the lipid kinase PI3K, and both are involved in cell proliferation and apoptosis. In infections of neuronal cells by dengue virus serotype 2 (dengue-2) and Japanese encephalitis virus, PI3K played an antiapoptotic role, and the blocking of PI3K activation enhanced virus-induced cytopathology with no effect on virus production (8). These multiple effects of Akt/PKB can modulate cap-versus internal ribosome entry site (IRES)-dependent translatio...